e49cfb8f-b741-4520-b841-ea4d8a4a8130.jpg

Research Resources

Upstream Disease Prevention Through Evidence-Based Intervention

The Birth & Evoluation of Diabetes Series 1 - 14

The Rapid Cognitive and Metabolic Toll of Excese Sugar for 4 days

The Birth & Evoluation of Diabetes Series 1A - 14

The Rapid Cognitive and Metabolic Toll of Excese Sugar Just 96 hours

The Birth & Evoluation of Diabetes Series 2 - 14

Type 2 Diabetes: Scientific Understanding & The Path of Hope

The Birth & Evoluation of Diabetes Series 3 - 14

How Diabetes is Generated?

The Truth Behind Diabetes

Truth Revealed Beyond the Veil of Conditioning

SUGAR-RELATED DISEASE SERIES-Diabetes Mellitus

Upstream Disease Prevention Through Evidence-Based Intervention

UPSTREAM DISEASE PREVENTION STATEMENT

This educational resource focuses on upstream disease prevention—preventing specific diseases before they occur through evidence-based interventions—rather than promoting general health.

Target diseases for prevention and control:

  • Type 2 Diabetes Mellitus (T2DM)

  • Cardiovascular Disease (CVD)

  • Neurocognitive Disorders (memory impairment, cognitive decline)

  • Diabetic Complications (nephropathy, retinopathy, neuropathy)

This resource is NOT 'promoting general health' material.

1. Disease Overview

1.1 Definition

Diabetes mellitus is a chronic metabolic disease characterised by elevated blood glucose levels (hyperglycaemia), resulting from defects in insulin secretion, insulin action, or both. Prolonged hyperglycaemia leads to long-term damage, dysfunction, and failure of multiple organs, including the eyes, kidneys, nerves, heart, and blood vessels.

1.2 Classification

Type

Characteristics & Pathophysiology

Type 1 (T1DM)

Autoimmune destruction of pancreatic β-cells, leading to absolute insulin deficiency. Accounts for 5-10% of cases. Requires lifelong insulin therapy.

Type 2 (T2DM)

Progressive insulin resistance and relative insulin deficiency. Accounts for 90-95% of cases. Strongly associated with dietary factors including excessive sugar consumption. PREVENTABLE and potentially REVERSIBLE.

Gestational (GDM)

Glucose intolerance first recognised during pregnancy. Increases maternal and offspring risk of future T2DM development.

2.1 High-Fat High-Sugar Diet: Neurocognitive Damage

Critical Research Findings (Macquarie University, Australia):

  • 4-day Western diet intervention: Impaired hippocampal-dependent learning and memory (Attuquayefio et al., 2017, PLoS One)

  • 8-day intervention: Declined appetitive control (d=0.47), correlated with memory decline (d=1.01)

  • Adolescent vulnerability: 23% reduction in hippocampal neurogenesis (Murray & Chen, 2019, Frontiers in Neuroscience)

THE VICIOUS CYCLE: HFHS diet → Hippocampus damage → Memory decline + Increased impulsivity → Greater difficulty resisting unhealthy foods → Further hippocampal damage

2.2 Type 2 Diabetes Pathophysiology

  1. Chronic excessive sugar intake (causative agent)

  2. → Persistent hyperglycaemia and hyperinsulinaemia

  3. → Progressive insulin resistance in peripheral tissues

  4. → Pancreatic β-cell exhaustion and dysfunction

Type 2 Diabetes Mellitus

3. Symptoms and Clinical Presentation

3.1 Classical 'Three Polys'

Polydipsia-Excessive thirst

Compensatory response to fluid loss

Polyuria-Frequent urination

Osmotic diuresis from glycosuria

Polyphagia-Excessive hunger

Cellular glucose deprivation despite hyperglycaemia

3.2 Other Common Symptoms

  • Unexplained weight loss (especially T1DM)

  • Fatigue and weakness

  • Blurred vision

  • Slow wound healing

  • Recurrent infections (skin, urinary tract, genital)

  • Paraesthesias (tingling/numbness in extremities)

References

Disclaimer

This document is for educational purposes only and does not constitute medical advice. Individual medical decisions should be made in consultation with qualified healthcare professionals. The information presented is based on peer-reviewed scientific research and international guidelines current at the time of publication.

Open Resource Sharing Statement

Open Resource — Redistribution Welcome: This educational resource may be freely shared and redistributed for non-commercial disease prevention purposes. Please attribute to: Vital Life Choice LTD (ABN: 20 695 710 082).

———————————————

Vital Life Choice LTD

Charity, not for profit. Science over suffering. Wisdom for wellbeing.

ABN: 20 695 710 082 | Adelaide, South Australia

09 Mar 2026 

Subscribe to us for more scientific truths about diabetes and chronic diseases.